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Abstract
During the lytic phase of infection, the gamma herpesvirus Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) expresses a
highly abundant, 1.1 kb nuclear noncoding RNA of unknown function. We observe that this polyadenylated nuclear (PAN)
RNA avidly binds host poly(A)-binding protein C1 (PABPC1), which normally functions in the cytoplasm to bind the poly(A)
tails of mRNAs, regulating mRNA stability and translation efficiency. During the lytic phase of KSHV infection, PABPC1 is re-
localized to the nucleus as a consequence of expression of the viral shutoff exonuclease (SOX) protein; SOX also mediates
the host shutoff effect in which host mRNAs are downregulated while viral mRNAs are selectively expressed. We show that
whereas PAN RNA is not required for the host shutoff effect or for PABPC1 re-localization, SOX strongly upregulates the
levels of PAN RNA in transient transfection experiments. This upregulation is destroyed by the same SOX mutation that
ablates the host shutoff effect and PABPC1 nuclear re-localization or by removal of the poly(A) tail of PAN. In cells induced
into the KSHV lytic phase, depletion of PAN RNA using RNase H-targeting antisense oligonucleotides reveals that it is
necessary for the production of late viral proteins from mRNAs that are themselves polyadenylated. Our results add to the
repertoire of functions ascribed to long noncoding RNAs and suggest a mechanism of action for nuclear noncoding RNAs in
gamma herpesvirus infection.
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Introduction
Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) is the
causative agent of several human cancers and immunoproliferative
disorders, including Kaposi’s Sarcoma, Multicentric Castleman’s
Disease and Primary Effusion Lymphoma [1,2]. Like other
herpesviruses, KSHV infection is characterized by two states:
viral latency and lytic growth. During latency, very few viral genes
are expressed, reducing the number of viral epitopes available to
trigger a host immune response. Given appropriate but incom-
pletely understood stimuli, the virus activates the lytic program of
infection. This is characterized by three ordered waves of viral
gene expression producing ‘‘immediate early,’’ ‘‘delayed early’’
and ‘‘late’’ proteins, as well as replication of the viral genome.
Ultimately, the new genomes are packaged into virions, which are
released from the cell for expansive host infection.
Upon KSHV entry into the lytic phase, an intronless viral
noncoding (nc)RNA called polyadenylated nuclear (PAN) RNA,
also known as T1.1 or nut-1, begins to be synthesized at unusually
high levels [3,4]. Although the 1.1 kb PAN RNA resembles an
mRNA in being transcribed by RNA polymerase II, methyl-G
capped at its 59 end, and polyadenylated at its 39 end, it is not
exported to the cytoplasm for translation as are other viral
transcripts. Instead, PAN RNA accumulates to astonishingly high
levels, reaching ,500,000 copies per nucleus and ultimately
accounting for up to 80% of the total polyadenylated RNA in the
cell [3]. Much has been learned regarding the mechanism that
enables PAN RNA to accumulate to such high levels. Specifically,
a 79-nucleotide element located near the 39 end of the RNA,
termed the expression and nuclear retention element (ENE), serves
to stabilize the RNA in the nucleus [5,6,7]. Deletion of the ENE
dramatically reduces the levels of transfected PAN RNA in HEK
293 cells, while insertion of the ENE into an intronless b-globin
transcript significantly increases its nuclear levels. Insertion of the
ENE has also been shown to enhance the abundance of nuclear
pri-miRNAs [8]. It was hypothesized that a U-rich internal loop
within the ENE engages the poly(A) tail, thereby sequestering it
from deadenylases that initiate RNA decay [6,7]. A recent x-ray
crystal structure of the ENE complexed with oligo(A) reveals the
formation of a triple helix that clamps the oligo(A) [9].
To address how PAN RNA contributes to lytic infection of
KSHV, we began by investigating protein components of the PAN
RNP and identified poly(A)-binding protein C1 (PABPC1).
PABPC1 normally functions in the cytoplasm where it binds the
poly(A) tails of mRNAs, regulating their stability by either
antagonizing or enhancing the activity of cytoplasmic dead-
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and enhances translation of mRNA via physical interactions with
the translation initiation factor eIF4G, and assists in the export of
mRNAs from the nucleus to the cytoplasm [14,15,16,17].
However, since PAN RNA resides exclusively in the nucleus of
KSHV-infected cells and does not shuttle (Conrad and Steitz,
unpublished observations), re-localization of PABPC1 to the
nucleus is a prerequisite for significant binding of PABPC1 to
PAN RNA. Indeed, several groups have reported that re-
localization of PABPC1 from the cytoplasm into the nucleus
occurs during lytic KSHV infection of TIME endothelial cells and
BC3 and BCBL1 TReX-RTA lymphoid cells [18,19,20]. The
phenomenon is driven by the shutoff exonuclease (SOX) protein,
as transient transfection of SOX into uninfected cells causes
nuclear accumulation of PABPC1 in the absence of any other viral
gene product [19]. SOX is also responsible for the host shutoff
effect of the virus, which selectively downregulates host mRNAs
while viral mRNAs persist [21,22,23]. SOX-mediated PABPC1
re-localization to the nucleus is critical for the host shutoff effect
since knockdown of PABPC1 diminishes the ability of SOX to
effect shutoff. GFP mRNA levels were downregulated in cells
transfected with SOX, but less so in cells pre-treated with anti-
PABPC1 siRNAs [19]. Furthermore, overexpression of PABPC1
targeted into the nucleus, using a nuclear retention signal from
hnRNPC1, recapitulates aspects of host shutoff in the absence of
any viral gene product [24]. Finally, a point mutation that disrupts
the ability of SOX to re-localize PABPC1, but does not disrupt
SOX’s unrelated function as an alkaline DNase, ablates its ability
to mediate host shutoff [19].
Here, we demonstrate that PAN RNA interacts with PABPC1
after it has re-localized to the nucleus during the lytic phase of
KSHV infection. In transient transfection experiments, SOX
strongly upregulates the levels of PAN RNA by a mechanism that
is dependent on the ability of SOX to mediate the host shutoff
effect, on the re-localization of PABPC1 into the nucleus and on
the existence of a poly(A) tail on PAN RNA. In infected cultured
cells activated into lytic phase, PAN RNA expression is coincident
with the host shutoff effect, and correlates with PABPC1 re-
localization from the cytoplasm into the nucleus. Yet, knockdown
of PAN RNA using RNase H-targeting oligonucleotides shows
that it is not required for the shutoff effect or the nuclear re-
localization of PABPC1. Instead, the amount of virus released into
the supernatant of cultured cells is severely reduced upon
knockdown. This striking effect on viral titer is explained by our
observation that knockdown of PAN RNA adversely affects the
expression of a subset of viral genes during the late stage of lytic
infection.
Materials and Methods
Cell lines, antibodies and transfection protocols
BCBL1 TReX-vector and TReX-RTA cells (gift from Jae Jung,
USC) were maintained in RPMI supplemented with pen/strep, L-
glutamine and 20% tetracycline-compatible FBS (Clonetech).
iSLK.219, 293 DC-SIGN (gift from Robert Means and Sabine
Lang, Yale University) and 293T cells were maintained in DMEM
supplemented with pen/strep, L-glutamine and 10% FBS. 293 tet-
on cells were maintained in DMEM supplemented with pen/strep,
L-glutamine and 10% tetracycline-compatible FBS. Anti-orf6/
SSB was a gift from G. Hayward (Johns Hopkins University), anti-
LANA1 and anti-orf4 were gifts from Y. Chang (University of
Pittsburg), anti-K8.1 antibody was from Advanced Biochemicals
Incorporated, anti-orf65 antibody was a gift from G. Miller (Yale
University), anti-myc antibody was from Santa Cruz Biotechnol-
ogy. Electroporation was conducted in 0.4 cm electroporation
cuvettes at 975 mF/220 mV for BCBL1 cells, and 975 mF/
210 mV for iSLK.219 cells. 293T cells were transfected with
MirusTransIT reagent according to the manufacturer’s protocol.
For some oligonucleotide knockdown experiments in BCBL1
TReX-RTA cells, cultures were first synchronized into S phase by
serum starvation for 24 hours, followed by the re-addition of
serum and incubation for 16 hours [25,26]. Cells were then
electroporated with RNase H-targeting modified oligonucleotides
and allowed to recuperate overnight in RPMI supplemented with
20% tetracycline-compatible FBS (Clonetech), followed by
induction the next day with 0.2 mg/mL doxycycline. Other
transfection methods were tested, such as nucleofection with both
Amaxa and Mirus reagents. Nucleofection with Amaxa reagent, as
per the manufacturer’s suggestions for BCBL1 cells, gave results
comparable in terms of knockdown efficiency and cell death to the
electroporation method used here.
Purification of PAN RNP
KSHV-infected BCBL1 TReX-vector or TReX-RTA cultures
were grown to a density of 0.8 million cells/mL, and then treated
with 2 ug/mL doxycycline for 24 hours. 100 million cells were
pelleted, washed with PBS, resuspended in 500 uL 50 mM Tris-
HCl, pH 7, 100 mM KCl, 10 mM MgCl2, 1 mM DTT, 10%
glycerol, 1 mM ATP, protease inhibitor cocktail (CalbioChem)
and RNase Inhibitor (Roche), and syringe lysed by 10 passages
through a 20G needle, 15 passages through a 25G7/8 needle and
20 passages through a 27G needle. Lysate was clarified by
spinning at 14,000 x g for 10 minutes at 4uC, before nutating with
500 mL bed volume DEAE-sepharose resin that had been pre-
equilibriated with lysis buffer. After 4 hours at 4uC, the resin was
pelleted at 3000 rpm for 1 minute at 4uC, washed twice with lysis
buffer, and subjected to successive batch elutions with increasing
concentrations of KCl in lysis buffer. Maximal yield of the PAN
RNP was observed in the 0.3 M KCl fraction. 1 mM MgCl2,
1.5 mM ATP, 5 mM creatine phosphate and 2–5 pmol/mLo f
biotinylated 29-O-methylated anti-PAN oligonucleotides, comple-
mentary to nucleotides 70 to 89 and 993 to 1012 of PAN RNA,
was added to 35 mL (175 mg) of the 0.3 M KCl fraction in a
Author Summary
Almost all eukaryotic messenger RNAs (mRNAs) have a
string of 150–200 adenylates at the 39 end. This poly(A) tail
has been implicated as important for regulating mRNA
translation, stability and export. During the lytic phase of
infection of Kaposi’s Sarcoma-Associated Herpesvirus
(KSHV), a noncoding viral RNA is synthesized that
resembles an mRNA in that it is transcribed by RNA
polymerase II, is methyl-G capped at the 59 end, and is
polyadenylated at the 39 end; yet this RNA is never
exported to the cytoplasm for translation. Rather, it builds
up in the nucleus to exceedingly high levels. We present
evidence that the function of this abundant, polyadenyl-
ated nuclear (PAN) RNA is to bind poly(A) binding protein,
which normally binds poly(A) tails of mRNAs in the
cytoplasm but is re-localized into the nucleus during lytic
KSHV infection. The interaction between PAN RNA and re-
localized poly(A) binding protein is important for forma-
tion of new virus, in particular for the synthesis of proteins
made late in infection. Our study provides new insight into
the function of this noncoding RNA during KSHV infection
and expands recent discoveries regarding re-localization of
poly(A) binding protein during many viral infections.
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was pre-blocked at 4uC for 15 minutes in 100 mg/mL E. coli
tRNA, 100 mg/mL glycogen and 1 mg/mL BSA, washed three
times in 20 mM Tris pH 7.6, 50 mM NaCl and 0.01% NP-40.
Extract was nutated with streptavidin beads at 4uC for 1 hour,
before pelleting, removing the supernatant, washing beads twice
with lysis buffer and eluting bound proteins by treatment with
micrococcal nuclease (Worthington Biochemical Corporation)
supplemented with 2 mM CaCl2 at 37uC for 30 minutes. Proteins
were fractionated by 10% SDS PAGE; the PAN RNP-specific
bands were excised and identified by mass spectrometry
(Columbia University). Further details on all peptides identified
in each band can be found at links provided in Fig. S2C.
Immunofluorescence experiments
BCBL1 TReX-vector or TReX-RTA cells were fixed onto glass
slides pre-treated with poly-L-lysine, fixed with 4% paraformal-
dehyde and permeabilized with 0.5% Triton-X. Anti-PAN RNA
oligonucleotides (SB2: ACAAATGCCACCTCACTTTGTCGC;
SB85: CGCTGCTTTCCTTTCACATT; SB88: GTGAAGCG-
GCAGCCAAGGTGACTGG), which were labeled with digox-
igenin-dUTP using the DIG oligonucleotide Tailing Kit (Roche),
were hybridized with the samples in 50% formamide, 10%
dextran sulfate, 2X SSC, 0.1% RNase-free BSA, 500 mg/mL
salmon sperm DNA, 125 mg/mL E. coli tRNA and 1 mM vanadyl
ribonucleoside complexes and detected using FITC-conjugated
anti-DIG antibody (Jackson Lab Immunologicals). PABPC1 was
visualized with anti-PABPC1 mouse monoclonal or rabbit
polyclonal antibodies (gift of G. Dreyfuss, UPenn, and Abcam),
and anti-mouse or anti-rabbit Alexa Fluor 594 antibody (Invitro-
gen). FLAG-PABPC1-NRS, a gift from B. Glaunsinger (UC
Berkeley), was visualized with rabbit anti-FLAG antibody (Sigma)
and anti-rabbit Alexa Fluor 594 (Invitrogen) [24]. rRNA was
visualized with Y10B mouse monoclonal antibody [27] and anti-
mouse Alexa Fluor 488 antibody (Invitrogen). Images were
collected on a Leica TCS SP5 confocal microscope.
Modified oligonucleotides
RNase H-targeting oligonucleotide [28,29] sequences used were
as follows. SB215 anti-PAN RNA oligo 1 (complementary to
nucleotides 70 to 89 of PAN RNA): mC*mC*mA*mA*mU*-
G*A*A*A*A*C*C*A*G*A*mA*mG*mC*mG*mG; SB216 anti-
PAN RNA oligo 2 (complementary to nucleotides 993 to 1012 of
PAN RNA): mU*mG*mA*mG*mC*T*C*T*A*G*G*C*A*C*G*-
mU*mU*mA*mA*mA; SB230 anti-GFP oligo: mC*mU*mG*-
mC*mC*A*T*C*C*A*G*A*T*C*G*mU*mU*mA*mU*mC; SB232
anti-K7 oligo (complementary to nucleotides -305 to -285 of K7
mRNA, with respect to the PAN RNA transcriptional start site):
mA*mA*mU*mC*mG*A*G*C*A*G*A*G*T*A*G*mC*mC*mA*-
fmA*mG, where m represents 29-O-methyl substitutions of the ribose
ring and * represents phosphorothioate substitutions.
Viral titer assays
BCBL1 TReX-RTA cells were induced with doxycycline for 8
days. Supernatant was collected, passed through a 0.45 micron
filter, and incubated with 6.25 mg/mL RNase A (Sigma) and 20
units/mL DNase One (New England Biolabs) for 1 hour at 37uC
to degrade extracellular RNA and any viral DNA that had not
been properly packaged into viral capsid protein and released
into the supernatant. The supernatant was then spun at
15,000 rpm using a Beckman TLA 100.2 rotor for 2 hours at
4uC, and the resulting pellet was resuspended in 600 mL of lysis
buffer (20 mM Tris-HCl pH 8.0, 10 mM EDTA, 100 mM NaCl
and 0.5% SDS) and incubated at room temperature for 10
minutes to inactivate the DNase. Following proteinase K
treatment (0.1 mg/mL final concentration and 2 hours incuba-
tion at 37uC), 3 ng of a control plasmid DNA was added to each
sample as a normalization control for loss of DNA during
subsequent steps of the purification process. After extraction with
phenol:chloroform:isoamyl alcohol (25:24:1), 600 mL of the
aqueous phase was precipitated with isopropanol, sodium acetate
and GlycoBlue (Ambion), and viral DNA levels were quantified
using qRT-PCR. The viral DNA signal was normalized to signal
from the control plasmid DNA (J. Ziegelbauer, personal
communication).
For measuring virus production from iSLK.219 cells, cells were
induced with doxycycline for 2-3 days, and supernatant was
collected and passed through a 0.45 micron filter. 50 mLo f
supernatant was added to 300 mL of DMEM +10% FBS and
placed on 293 DC-SIGN cells that had been grown in 12-well
plates. Cells were then spun at 2000 rpm for 1 hour at room
temperature in a Beckman Coulter J6-MI centrifuge fitted with a
JS-4.2A rotor [30]. 48 hours later cells were harvested by trypsin,
washed with PBS and fixed with 4% formaldehyde in PBS for 30
minutes at room temperature. GFP levels were quantified by flow
cytometry using BD Biosciences’ FACSCalibur platform.
Intracellular viral DNA replication assays
BCBL1 TReX-RTA cells were electroporated and induced as
above for 3 days. 5 million live cells were washed with PBS,
resuspended in 250 mM Tris pH 8.5, 125 mM EDTA, 1 mg/mL
protease K and 1% SDS, and incubated at 60uC for 2 hours. 1/
5th volume of 5 M potassium acetate pH 5.2 was added, lysate
was incubated on ice for 20 minutes, and clarified by
centrifugation at 12,000 rpm for 15 minutes at 4uC. Supernatant
was transferred to a fresh tube, and incubated with 20 mg/mL
RNase A at 37uC for 15 minutes. Then, 2.5-fold volume of ice-
cold 100% ethanol was added, and DNA was precipitated
overnight at 220uC. Pellets were resuspended in 100 mL water,
and viral DNA levels were measured by qRT-PCR as above,
normalizing to human DNA using GAPDH-specific primers.
Results
PABPC1 associates with PAN RNA in the nucleus of
BCBL1 TReX-RTA cells
To determine what proteins bind to PAN RNA in the nucleus
of lytically infected cells, we isolated the PAN RNP from a
KSHV-infected cell line containing a doxycycline-inducible
version of RTA (BCBL1 TReX-RTA), the viral transcription
factor that is necessary and sufficient to promote entry into the
lytic phase of viral infection [31,32,33]. After anion exchange and
affinity chromatography using a selection oligonucleotide com-
plementary to PAN RNA (Fig. 1), we identified both hnRNP C1/
C2 and PABPC1 as specifically co-purifying with PAN RNA (see
Fig. S1 and S2 for fractionation and mass spectrometry data).
These proteins were not seen when extracts from the control
doxycycline-treated BCBL1 TReX-vector cell line were used.
hnRNP C1 has been previously observed to bind to PAN RNA,
although the significance of this interaction is not understood
[34].
Since PAN RNA is exclusively nuclear, proteins that interact
with PAN RNA must reside in the nucleus. While PABPC1 is
essentially a cytoplasmic protein, nuclear re-localization of
PABPC1 during KSHV lytic phase had been reported in the
literature [18,19,20]. We therefore performed immunofluores-
cence experiments to confirm that PABPC1 re-localizes into the
nucleus of the BCBL1 TReX-RTA cells [20] and to establish
Late Viral Protein Expression Depends on KSHV PAN RNA
PLoS Pathogens | www.plospathogens.org 3 October 2011 | Volume 7 | Issue 10 | e1002300whether this re-localization correlates with the expression of PAN
RNA. Cells were fixed and stained with primary and secondary
antibodies to visualize PABPC1, and in situ hybridization probes
and detection antibodies to visualize PAN RNA. As seen in
Fig. 1C, PABPC1 indeed re-localizes into the nucleus during lytic
infection, and the subnuclear distribution of PAN RNA and of re-
localized PABPC1 appear strikingly similar. rRNA, however,
remains predominantly cytoplasmic during both latent and lytic
stages of infection (Fig. S3). We manually scored the immunoflu-
orescence pattern of several hundred cells from a number of
microscopic fields, and found that ,80% of the cells in which
PABPC1 had re-localized into the nucleus also expressed PAN
RNA (representative images from the manual scoring experiment
are provided in Fig. S4). The coincidence of PABPC1 re-
localization and PAN RNA expression was further verified in
the original BCBL1 cell line (data not shown). High throughput
analysis, using multispectral imaging flow cytometry (Amnis
Corporation), of PABPC1 nuclear re-localization and PAN RNA
expression in BCBL1 cells has extended this correlation (S. Borah,
L. Hassman, D.H. Kedes and J.A. Steitz, manuscript in
preparation).
Additionally, we noted that unique peptides in the mass
spectrometry data also identified PABPC4 as a protein that co-
purifies with PAN RNA (Fig. S2A). Recently, nuclear re-
localization of this protein has also been reported to result from
KSHV lytic infection; knockdown of both PABPC1 and PABPC4
in transient SOX-transfection experiments revealed that these
proteins might have redundant functions with respect to SOX-
mediated nuclear retention of polyadenylated RNA in 293T cells
[24].
Figure 1. PAN RNA binds to PABPC1 in the nucleus of lytically infected BCBL1 TReX-RTA cells. A. Scheme for biochemical purification of
the PAN RNP. B. 10% SDS-PAGE gel silver-stained to show proteins co-purifying with PAN RNA from lysates of doxycycline-treated BCBL1 TReX-vector
cells (left lane) or BCBL1 TReX-RTA cells (right lane). C. Dual immunofluorescence and in situ hybridization for PABPC1 (red) and PAN RNA (green) from
BCBL1 TReX-vector cells (top panels) or BCBL1 TReX-RTA cells (bottom panels) treated with doxycycline.
doi:10.1371/journal.ppat.1002300.g001
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re-localization of PABPC1 into the nucleus, as directed by
the SOX protein
Since SOX induces both host shutoff and the nuclear
accumulation of PABPC1 [19,22], and since PAN RNA binds
re-localized PABPC1 in the nucleus (see Fig. 1), we hypothesized
that PAN RNA might be involved in the host shutoff effect
mediated by SOX. To elucidate the relationship between PAN
RNA, the SOX protein and the host shutoff effect, we co-
expressed PAN RNA and SOX protein in transient transfection
experiments, in the absence of other viral genes. As seen in Fig. 2A,
transfection of SOX protein into 293 tet-on cells had no effect on
18S rRNA or the RNase P RNA, which are normally unaffected
during host shutoff, but resulted in a modest 2- to 4-fold reduction
in the level of endogenous GAPDH mRNA and a 2- to 3-fold
reduction in the level of co-transfected GFP mRNA. In contrast,
transfection of SOX very strongly stimulated the level of PAN
RNA (20- to 30-fold). This stimulation was independent of the
tetracycline-regulated promoter used to express PAN RNA, as
upregulation was observed in experiments using PAN’s endoge-
nous RTA-dependent promoter (Fig. 2B and 2C) or a CMV
promoter (data not shown).
The effect of SOX on PAN levels was also seen by
immunofluorescence (Fig. 2B). When a PAN RNA expression
vector that includes 1 kb of PAN’s endogenous, RTA-responsive
promoter was co-transfected into 293T cells with an RTA
expression plasmid, only an occasional in situ hybridization signal
for PAN RNA was observed (see Fig. 2B, middle right panel).
However, when the SOX gene was co-transfected, the PAN RNA
in situ hybridization signal was robust (bottom right panel).
Furthermore, those cells in which a robust PAN RNA in situ signal
was observed were the same cells in which PABPC1 had re-
localized to the nucleus (Fig. 2B, middle column). This suggested
that high levels of PAN RNA expression are not only dependent
on SOX expression, but might also involve PABPC1 re-
localization. Accordingly, when a mutant version of PAN RNA
in which the poly(A) tail was replaced by a 39 stem-loop structure
derived from a histone mRNA [6] was transfected into these cells,
SOX-mediated enhancement of PAN RNA levels was reduced by
about 6-fold (see Fig. 2A, PAN RNA D-poly(A) tail, and Fig. S5).
The SOX protein is a dual-function protein, acting both as the
mediator of the host shutoff effect and as an alkaline exonuclease
that is important for processing the viral DNA [35]. These two
functions are separable; point mutants that are unable to carry out
the shutoff function are wild-type for exonuclease function, and
vice versa. Moreover, mutations that inactivate only the shutoff
function of the protein also ablate its ability to re-localize PABPC1
into the nucleus, arguing for a link between these phenomena. We
therefore tested each of these mutants to determine which function
of SOX is responsible for the strong stimulation of PAN RNA
levels. As seen in Fig. 2C, the P176S SOX mutant, which retains
exonuclease activity but does not mediate host shutoff, failed to
enhance PAN RNA expression. Conversely, the Q129H mutant,
which retains host shutoff but does not exhibit exonuclease
activity, stimulated PAN RNA expression to the same extent as
wild-type SOX. These results indicate that SOX’s exonuclease
activity is not required for its stimulatory effect on PAN RNA.
They are also consistent with the possibility that upregulation of
PAN is mediated by SOX’s host shutoff function and ability to re-
localize PABPC1.
To address whether nuclear localized PABPC1 alone can
upregulate levels of PAN RNA, in the absence of SOX, we co-
transfected genes for PAN RNA and a mutant PABPC1-NRS that
is retained in the nucleus [24]. As seen in Fig. 2D, co-expression of
PABPC1-NRS resulted in upregulation of PAN RNA. As with
SOX expression, upregulation of PAN RNA levels were specific to
those cells in which nuclear retention of PABPC1 had occurred
(Fig. 2E). While this result clearly demonstrates that nuclear
accumulation of PABPC1 results in increased PAN RNA levels,
the levels of PAN RNA did not reach levels seen upon co-
transfection with SOX (see Fig. 2D). This may be due to a
different efficiency of PABPC1 nuclear re-localization in SOX-
transfected versus PABPC1-NRS-transfected cells, or due to some
other aspect of SOX expression that further augments PAN RNA
expression, in addition to the nuclear localization of PABPC1.
A previous study showed that although SOX and its murine
herpesvirus-68 homolog reside in both the nucleus and cytoplasm,
it is the cytoplasmic fraction of these proteins that is responsible for
the host shutoff effect and for PABPC1 re-localization [36]. A
more recent study demonstrated that SOX promotes PABPC1 re-
localization by depleting cytoplasmic polyadenylated RNA, which
in turn allowed direct intereaction between PABPC1 and importin
a [37]. The fact that upregulation of PAN by SOX (Fig. 2A and B)
depends on the nuclear re-localization of PABPC1, as well as on
the presence of PAN’s poly(A) tail, suggests how cytoplasmic SOX
protein strongly upregulates the levels of a nuclear RNA: SOX
indirectly enhances PAN abundance through re-localizing
PABPC1, which in turn stabilizes PAN RNA by binding to its
poly(A) tail. This scenario is consistent with the role of poly(A) tails
as stabilizing constituents of mRNAs by antagonizing deadenylases
[14] and with the presence of nuclear degradation factors that
destabilize PAN in the absence of its poly(A) tail [6].
PAN RNA expression is coincident with but nonessential
for the KSHV host shutoff effect
If increased levels of PAN RNA in the nuclei of lytically
reactivated cells are due to PABPC1 re-localization, as observed in
transiently transfected cells (Fig. 2), then PAN RNA should
accumulate at the same time during the course of KSHV infection
that host mRNA levels decrease because of the shutoff effect. To
test this, BCBL1 TReX-vector or TReX-RTA cells were induced
into lytic phase, and total RNA was extracted from culture samples
after different times. Northern blot and qRT-PCR analysis (Fig. 3A
and B) showed that increases in SOX and PAN RNAs coincide
with the decrease in b-actin and GAPDH mRNA (,12–24 hours
post-induction). Thus, PAN RNA expression correlates with the
host shutoff effect in the context of actual viral infection.
Furthermore, at approximately the same time during the course
of lytic infection, PABPC1 re-localizes into the nucleus (data not
shown and [19]).
To ask whether lytic induction results in the accumulation of
other abundant, polyadenylated noncoding RNAs coincident with
PABPC1 re-localization, we measured the levels of host MALAT1
and NEAT1 RNAs by northern blot and qRT-PCR. MALAT1
RNA exists either as a long polyadenylated transcript that localizes
to nuclear speckles, or a shorter transcript that localizes to the
cytoplasm [38]. Similarly, NEAT1 RNA exists either as a shorter
polyadenylated transcript or a longer transcript whose 39 end is
generated by endonucleolytic cleavage by RNase P [39]. We
observed that the levels of the nuclear, polyadenylated forms of
MALAT1 or NEAT1 RNA did not increase dramatically (Fig. 3A
and C) but rather declined in abundance during lytic infection,
after normalization to 18S rRNA levels. Thus, PAN RNA
selectively accumulates in the nucleus during the KSHV lytic
phase, while two other similar noncoding polyadenylated RNAs,
MALAT1 RNA and NEAT1 RNA, do not.
To investigate whether PAN RNA expression directly
contributes to the host shutoff effect and/or PABPC1 re-
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the levels of PAN RNA using 29-O-methylated and phosphor-
othioate-substituted antisense oligonucleotides that target
endogenous RNase H to cleave PAN RNA (a-PAN oligos 1
and 2 in Fig. 4A) [28]. Interpretation of PAN knockdown
experiments is complicated by the fact that the region of the
KSHV genome from which PAN RNA is transcribed is
included in the overlapping K7/survivin transcript (Fig. 4A)
[40]. To differentiate between the involvement of PAN RNA
and the K7/survivin protein, we designed an additional
antisense oligonucleotide that targets the K7 transcript in a
region not included in the sequence of PAN RNA (a-K7 oligo
in Fig. 4A). We reasoned that any results of transfection of
oligonucleotides targeting both PAN RNA and K7 mRNA
Figure 2. SOX stimulates PAN RNA expression in transient transfection assays. A. Northern blot analysis of total RNA extracted from 293
tet-on cells transfected with: 1) a GFP expression vector, 2) a PAN RNA or PAN/U7 39-end (PAN RNA D-poly(A) tail) expression vector driven from a
tetracycline-regulated promoter, and 3) either blank DNA (left lanes) or a SOX-expression vector (right lanes). The blot was sequentially probed for the
RNAs listed on the right. B. Confocal images of dual immunofluorescence/in situ hybridization staining for PABPC1 (red) and PAN RNA (green) in
transiently transfected 293T cells. Cells were transfected with: 1) empty plasmid (top panels), 2) a PAN RNA expression vector driven from the
endogenous RTA-responsive PAN promoter and an RTA expression vector (middle panels), or 3) a PAN RNA expression vector driven from the
endogenous RTA-responsive PAN promoter, an RTA expression vector and a SOX-expression vector (bottom panels). C. Top two panels: northern blot
analysis for 18S or PAN RNA in total RNA extracted from 293T cells transfected with: 1) PAN RNA driven from its endogenous promoter, 2) an RTA
expression vector, and 3) either empty plasmid, an expression vector for wild-type SOX, the P176S mutant SOX or the Q129H mutant SOX. Bottom
two panels: western blots showing equal levels of expression of all three SOX proteins. D. Northern blot analysis of total RNA extracted from 293T
cells transfected with an RTA expression vector, a PAN RNA expression vector driven from the endogenous PAN promoter and either blank DNA (left
lane), a PABPC1-NRS expression vector (center lane) or a SOX expression vector (right lane). E. Confocal images of dual immunofluorescence/in situ
hybridization staining for FLAG-tagged PABPC1-NRS (red) and PAN RNA (green) in transiently transfected 293T cells.
doi:10.1371/journal.ppat.1002300.g002
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progression of lytic reactivation by doxycycline treatment of BCBL1 TReX-vector (left) or BCBL1 TReX-RTA (right) cells. B. qRT-PCR data from a
representative experiment showing increased expression of PAN RNA versus the decline in host GAPDH mRNA. C. qRT-PCR data from a representative
experiment showing that host MALAT1 and NEAT1 RNAs decline during lytic infection. qRT-PCR signals were normalized to endogenous 18S rRNA.
doi:10.1371/journal.ppat.1002300.g003
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transfection of the K7-specific oligonucleotide (a-K7 oligo)
would be specifically due to PAN RNA knockdown. First, we
showed by qRT-PCR that the K7-specific oligonucleotide
selectively lowered the level of the K7 mRNA ,20-fold
( F i g .4 B ) .H o w e v e r ,t h eK 7 - s p e c i f i co l i g o n u c l e o t i d ed i dn o t
downregulate levels of PAN RNA, as seen in the northern blot
of Fig. 4C. The combination of the two anti-PAN RNA
oligonucleotides decreased not only PAN RNA to 5%–10% of
wild-type levels in BCBL1 TReX-RTA cells (see Fig. 4C), but
also the K7 mRNA, as expected (see Fig. 4B). Thus, differential
knockdown of the overlapping K7 and PAN transcripts can be
achieved by use of modified oligonucleotides.
Revealingly, the anti-PAN oligonucleotides had no effect on the
host shutoff effect, as indicated by GAPDH and b-actin mRNA
levels, despite a knockdown of PAN RNA levels by ,90%–95%
(Fig. 5). Transfection with a GFP- or K7-specific control
oligonucleotide also did not alter the magnitude of host shutoff
in BCBL1 TReX-RTA cells (Fig. S6). Confocal analysis indicated
that PABPC1 was re-localized into the nucleus of BCBL1 TReX-
RTA cells upon lytic induction despite PAN RNA knockdown
(data not shown). We conclude that the expression of PAN RNA
may be related to but is not required for SOX-dependent host
shutoff during the KSHV lytic phase.
PAN RNA is required for expression of a subset of viral
genes
Since knockdown of PAN RNA does not appear to affect the
SOX-induced shutoff of host protein synthesis, we asked whether
PAN RNA might alter the expression of viral proteins instead. We
compared the effects of knockdown of PAN RNA on viral protein
expression in two different cells lines: BCBL1 TReX-RTA cells,
which harbor the authentic KSHV virus, and iSLK.219 cells, in
which the recombinant rKSHV.219 virus has been re-introduced
into a KS cell line that has lost the original KSHV genome
[41,42]. In both these cell lines, the virus is induced into lytic phase
by overexpression of RTA controlled by a tetracycline-responsive
promoter.
Western blot analyses of lysates from BCBL1 TReX-RTA that
had been transfected with no (mock), anti-GFP, anti-K7 or anti-
PAN RNA oligonucleotides revealed that knockdown of PAN
RNA affects late rather than early KSHV proteins (Fig. 6). Several
early viral proteins, such as Orf50/RTA, vIL-6 and Orf6/ssDNA-
binding protein (Fig. 6A), as well as the latency-associated nuclear
antigen Orf73/LANA1 (data not shown), accumulate normally. In
contrast, the levels of the late viral proteins K8.1 and Orf65/small
viral capsid antigen (Fig. 6A), as well as Orf4/complement-binding
protein (data not shown) were significantly lowered upon
knockdown of PAN RNA, compared to the control oligonucleo-
Figure 4. PAN RNA and K7 mRNA levels are reduced by transfection of RNase H-targeting oligonucleotides. A. Region of the KSHV
genome from which K7 mRNA and PAN RNA are transcribed. Alternative transcriptional start sites for the K7 mRNA isoforms [40], regions targeted by
anti-K7 (a-K7) and anti-PAN RNA (a-PAN) 1 and 2 modified oligonucleotides, as well as the oligonucleotide probe used to detect PAN RNA by
northern blot, are indicated. The K7 ORF, ENE and poly(A) signal shared by all four RNA species are shown. B. K7 mRNA levels at 0, 10.5 or 24 hours
post-induction of BCBL1 TReX-RTA cells after recovery from electroporation with a-GFP, a-K7 or a-PAN RNA 1 and 2 oligonucleotides. qRT-PCR signals
were normalized to endogenous 18S rRNA. C. Northern blot analysis of total RNA extracted from BCBL1 TReX-RTA cells electroporated with different
concentrations of a-GFP, a-K7 or a-PAN RNA 1 and 2 oligonucleotides and at 0, 12 or 24 hours post-induction.
doi:10.1371/journal.ppat.1002300.g004
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two different methods (see Fig. S7 legend for description of
methods) of the immunoblot signals for the immediate early
protein RTA, early protein vIL-6 and late protein K8.1 from 9
independent experiments are averaged in Fig. 6B (7 independent
experiments for signal from cells transfected with anti-K7
oligonucleotide). The efficiency of PAN RNA knockdown ranged
from 75% to 95% (data not shown) and the immunoblots from all
9 experiments are presented in Fig. S7. Together these data
demonstrate the selective downregulation of the late protein K8.1
upon knockdown of PAN RNA.
Although non-specific toxic effects were experienced upon
electroporation followed by lytic induction, particularly in the
BCBL1 TReX-RTA cells (see Materials and Methods), similar
levels of cell death were seen regardless of the oligonucleotide
transfected (Fig. 6C). Cultures were routinely stained by trypan
blue and scored for percent viability prior to harvest in order to
analyze lysate from the same number of living cells for each
condition. Thus, the loss of late gene expression in PAN
knockdown cells is not due simply to increased levels of cell death.
Likewise, several lines of evidence indicate that the decreased
levels of late protein expression observed upon knockdown of PAN
RNA are not simply due to a non-specific decrease in RTA
expression. Although some of the 9 immunoblot experiments
revealed a decrease in RTA expression upon transfection with the
K7 and PAN RNA oligonucleotides (Fig. 6B), in others a
significant decrease in K8.1 expression was observed despite
robust expression of RTA (see Fig. S7, panels A, D, E, G and H).
Moreover, an independent assay was devised to test whether the
effect of PAN RNA knockdown on K8.1 was due to decreased
RTA expression. The expression levels of both K8.1 and myc-
tagged RTA were measured by dual immunofluorescence staining
Figure 5. PAN RNA does not contribute to the host shutoff effect. Northern blot of total RNA harvested from BCBL1 TReX-RTA cells
electroporated with increasing concentrations of a-PAN RNA 1 and 2 oligonucleotides at various times after doxycycline-mediated induction, probed
for the RNAs indicated on the right. The faster migrating band in lanes 3 and 6 of the GAPDH panel is residual
32P-labeled anti-PAN RNA probe.
doi:10.1371/journal.ppat.1002300.g005
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positive BCBL1 TReX-RTA cells revealed that fewer cells
expressed K8.1 upon knockdown of PAN RNA (Fig. S8).
Importantly, since K8.1 expression was scored only in cells that
also expressed RTA, the observed effect could not be due to
decreased RTA expression. We conclude that the effect of PAN
Figure 6. Knockdown of PAN RNA expression adversely affects late gene expression in BCBL1 TReX-RTA cells. A. BCBL1 TReX-RTA cells
were electroporated with the indicated modified oligonucleotides and induced with doxycycline 12–16 hours later. After various times, lysates from
equivalent numbers of living cells were loaded in each lane, and blotted proteins were probed sequentially with antibodies against the indicated
proteins. B. Densitometric analysis of immunoblot signals (see Fig. S6 legend) for RTA (immediate early protein), vIL-6 (early protein) and K8.1 (late
protein) after knockdown with control or a-PAN RNA oligonucleotides. Standard error of the mean from 9 experiments (7 experiments for a-K7
knockdown) is shown. C. Cell viability was measured by trypan blue staining 24 hours post-induction. Averages and standard error of the mean from
7 independent experiments are shown.
doi:10.1371/journal.ppat.1002300.g006
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on RTA.
The results of PAN RNA knockdown in iSLK.219 cells were
also assessed (Fig. 7A). Knockdown efficiency in this cell line was
90%–95% (data not shown). In iSLK.219 cells, knockdown of
PAN RNA resulted in some decrease in all viral proteins tested,
including the early proteins Orf6/ssDNA binding protein and vIL-
6 (Fig. 7A). However, the effect on the late K8.1 protein was much
more pronounced: K8.1 protein levels dropped 12.5-fold in cells
transfected with anti-PAN oligonucleotides compared to cells
transfected with anti-K7 oligonucleotide (Fig. 7B), whereas vIL-6
protein levels decreased only 2.5-fold. We conclude that PAN
RNA preferentially enhances the expression of late viral proteins
in KSHV-infected cells.
Knockdown of PAN RNA decreases viral titers
Since knockdown of PAN RNA adversely affects expression of
important late viral genes, we predicted that its knockdown would
affect overall viral yield. To assess the role of PAN RNA in the
production of new virus, we harvested virus from the supernatant
of induced BCBL1 TReX-RTA cells 8 days post-induction. As
seen in Fig. 8A, knockdown of PAN RNA significantly reduced
viral production, as assayed by qPCR measurement of DNase
resistant, encapsulated viral DNA released into the supernatant.
The effect was comparable to treatment with ganciclovir, an
inhibitor of viral DNA replication [43,44].
The effect of PAN RNA knockdown on production of infectious
virus from iSLK.219 cells was also assayed by harvesting the
supernatant from induced iSLK.219 cells and infecting target 293
cells that stably express the DC-SIGN receptor. Infection was
assessed by visualization (Fig. 7C) and by FACS analysis of GFP
expression arising from the recombinant KSHV genome in target
cells 48 hours later. Fig. 7C reveals that treatment of iSLK.219
cells with anti-PAN RNA oligonucleotides resulted in virtually no
GFP-positive 293 DC-SIGN cells upon infection with virus
harvested from cells treated with anti-PAN oligonucleotides.
However, GFP-positive cells were detected among 293 DC-SIGN
cells incubated with virus harvested from cells treated with the
anti-K7 oligonucleotide. Thus, release of infectious virus as well as
encapsulated viral DNA levels were both diminished by knocking
down PAN RNA.
Since viral DNA replication is required for the expression of
herpesvirus late proteins [45,46,47], the effect of PAN RNA
knockdown on the accumulation of intracellular viral DNA during
the lytic phase was also measured by qPCR. Increases in
intracellular viral DNA levels 4 days post-induction in BCBL1
TReX-RTA cells were very modest (,5–7 fold), in agreement
with other reports [48,49]; this level was further decreased when
cells were electroporated prior to induction. The low levels of
intracellular viral DNA make it difficult to conclude definitively
whether the knockdown of PAN RNA specifically inhibits viral
DNA replication. However, no dramatic differences in intracel-
lular viral DNA levels were detectable in cells transfected with
control versus anti-PAN RNA oligonucleotides (Fig. 8B), suggest-
ing that PAN RNA is not directly involved in viral DNA
replication.
Discussion
A noncoding RNA is important for viral gene expression
during the KSHV lytic phase
The data presented here indicate that the highly abundant PAN
RNA binds to the normally cytoplasmic poly(A) binding protein
PABPC1 once it has been re-localized to the nucleus of KSHV-
infected cells (Fig. 1). This is supported by both the composition of
the PAN RNP and the observation that the detailed patterns of
PAN RNA and PABPC1 concentration within the nucleus
coincide. The abundance of PAN RNA (upwards of 0.5610
6
transcripts per nucleus) corresponds well to the abundance of
PABPC1 (estimated at 7610
6 copies in the average HeLa cell),
given that the length of PAN RNA’s poly(A) tail is estimated to be
similar to that of the average host mRNA (Conrad and Steitz, data
not shown) and that each PAN RNA thus likely binds 8–10
PABPC1 molecules [3,50]. Our results extend prior reports of
PABPC1 re-localization by SOX protein alone and the concurrent
host shutoff effect [19] by showing that that the level of PAN RNA
is likewise dependent on expression of the SOX protein in
transient transfection assays (Fig. 2). In infected cells, PAN RNA is
not required for the re-localization of PABPC1 nor for the host
shutoff effect (Fig. 5), which promotes this re-localization.
Since PAN RNA expression is concurrent with the host shutoff
effect in the context of viral lytic infection (Fig. 3), PAN RNA likely
functions downstream of SOX action. An alternative possibility-
that RTA levels (and therefore all late functions) are compromised
by treatment with anti-PAN oligonucleotides-is not consistent with
several observations. Because lytic reactivation is dependent on
RTA expression, an across-the-board reduction in all lytic-related
events would be expected but was not observed. Specifically, PAN
RNA knockdown did not affect: 1) the host shutoff effect and
PABPC1 nuclear re-localization (Figs. 5 and S6 and data not
shown), 2) accumulation of intracellular viral DNA (Fig. 8B), and
3) expression of the viral lytic marker vIL-6 (Fig. 6A, B). Instead,
knockdown of PAN RNA adversely affected the expression of late
viral genes in cells of both lymphoid (BCBL1, Figs. 6, S7 and S8)
and endothelial (iSLK.219, Fig. 7) origin, which are two major
KSHV targets in vivo.
Ultimately, knockdown of PAN RNA adversely affects release of
new infectious virus into the supernatant from BCBL1 TReX-
RTA cells (Fig. 8A), as would be expected from the downregu-
lation of late viral gene expression. This effect appears to be
independent of viral DNA replication (Fig. 8B). We conclude that
PAN RNA plays an important role in the expression of a subset of
viral genes, perhaps related to the nuclear re-localization of
PABPC1. Further work is needed to establish whether this effect is
at the level of transcription, translation or mRNA stability,
although selective downregulation of mRNAs for the late genes
K8.1, Orf18 and Orf29 was observed using qRT-PCR analysis
(data not shown). It is also possible that the effects seen on virus
production and late viral protein expression result from dual
Figure 7. Knockdown of PAN RNA adversely affects gene expression in iSLK.219 cells, with a more pronounced effect on late genes.
A. Procedures were the same as in Fig. 6 B. Densitometric analyses of immunoblot signals of RTA (immediate early protein), vIL-6 (early protein) and
K8.1 (late protein) after knockdown with control or a-PAN RNA oligonucleotides. Standard error of the mean from 4 experiments is shown. C. GFP
expression in target 293 DC-SIGN cells after inoculation with media from iSLK.219 cells treated with no oligonucleotide (mock), a-K7 oligonucleotide
or a-PAN RNA oligonucleotides 48 hours after induction with doxycycline. FACS sorting of cells indicated mean fluorescence intensities (in arbitrary
units) of 0.07+/2 0.04 for uninfected cells, 1.00 for cells infected with supernatant from mock-transfected iSLK.219 cells, 0.14+/2 0.08 for cells
infected with supernatant from anti-K7-transfected iSLK.219 cells and 0.05+/2 0.03 for cells infected with supernatant from anti-PAN-transfected
iSLK.219 cells. Standard error of the mean for 3 independent experiments is given.
doi:10.1371/journal.ppat.1002300.g007
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knockdown of PAN RNA is required to observe these effects, as
K7 knockdown alone is insufficient, underscores the importance of
PAN RNA.
KSHV targets host gene expression at several levels during the
lytic phase. First, host mRNA levels are specifically downregulated
by the SOX protein, a phenomenon that is itself related to nuclear
re-localization of PABPC1, a highly abundant translation factor
that displays nanomolar affinity for the polyadenylate tails of
mRNAs [24,50]. Rowe and colleagues have found that the Epstein
Barr virus SOX homolog BGLF5 mediates host shutoff in EBV-
infected cells [51], and Glaunsinger and colleagues have extended
their findings of SOX function to the homologous murine
herpesvirus-68 (MHV-68) protein [36]. Both EBV and MHV-68
SOX homologs drive PABPC1 re-localization into the nucleus,
like their KSHV-counterpart [19], and we have extended the
observation of PABPC1 nuclear re-localization to EBV-infected
HH514-16 cells upon lytic activation (S. Borah, R. Park, G. Miller
and J.A. Steitz, unpublished observations). Second, in addition to
the downregulation of host mRNA levels, other changes in host
translation during the KSHV lytic phase [20] have been reported
to include increased levels of 4E-BP1 and eIF4E phosphorylation,
which are expected to enhance rates of eIF4F assembly onto and
of translation of viral mRNAs. Third, KSHV mRNAs, many of
which are unspliced, are preferentially exported by the viral export
factor Orf57, which tethers the nuclear export factor TAP protein
to viral mRNAs and enhances their translation [52,53,54].
Our data support a model in which the highly abundant PAN
RNA contributes importantly to the viral manipulation of gene
expression. Aspects of viral infection that downregulate host gene
expression, such as host shutoff and PABPC1 re-localization, do
not require PAN RNA, but instead affect the expression level of
PAN RNA itself both in transiently transfected cells and in bona
fide infected cells. PAN RNA then impacts the expression of at
least a subset of viral genes; possible molecular mechanisms for this
regulation are presented below.
Viral targeting of PABP
Poly(A) binding protein is a central player in cellular gene
expression and is targeted by a number of viruses, usually as a
means to achieve shutdown of host gene expression. Some, such as
picornaviruses and caliciviruses, have evolved specific proteases
that cleave PABPC1 [55,56,57]. Rotavirus instead expresses the
NSP3 protein, which displaces PABPC1 from binding to eIF4G.
This reduces the translational efficiency of host mRNAs, whereas
viral mRNAs, which lack a poly(A) tail, are efficiently translated
[58]. Expression of NSP3 also leads to nuclear accumulation of
PABPC1, although the significance of this re-localization is not
fully understood [59,60]. Nuclear re-localization of PABPC1 is
also observed during infection with Bunyamwera virus. Further-
more, although siRNA-mediated knockdown of PABPC1 de-
creased translation of a polyadenylated luciferase reporter,
translation of a reporter whose 39 end was derived from
Bunyamwera virus mRNA, and thus lacked a poly(A) tail, was
unaffected by knockdown [61].
PABPN1, a distinct nuclear poly(A) binding protein [14], is also
targeted by viruses. Influenza NS1 protein binds both PABPN1
and the cleavage and polyadenylation stimulation factor (CPSF)
within the assembled 39-end processing machinery [62]. Thus,
poly(A) polymerase does not processively extend the poly(A) tail of
nascent mRNAs past ,12 residues, and multiple PABPN1
molecules do not assemble onto the mRNA. This failure to
properly form a poly(A) tail [63] and interact with PABPN1 are
thought to underlie the lack of host mRNA export during
influenza virus infection [64]. NS1 has other effects on PABPN1 as
well, including inhibition of PABPN1 shuttling and re-distribution
of PABPN1 from nuclear speckles to a uniform pattern throughout
the nucleoplasm [62]. However, to date, no role for a noncoding
RNA has been identified in the mechanisms by which these viruses
target PABPC1 for host shutoff.
Homologs of PAN RNA?
Given the striking abundance of PAN RNA and the role that it
plays in KSHV gene expression within the context of PABPC1 re-
localization, it might be expected that homologs of this RNA
would be found in related herpesviruses in which re-localization of
PABPC1 occurs. Viruses whose mRNAs lack poly(A) tails, such as
rotavirus and Bunyamwera virus, would be exceptions. Indeed, the
EBV homolog of the SOX protein, BGLF5, has been shown to
mediate host shutoff in cells infected with EBV and to drive
PABPC1 re-localization [36,51]. Although no PAN-like RNA has
yet been reported in EBV or other herpesviruses, we have recently
discovered putative homologs in several members of the gamma
herpesvirus family. Indeed, expression of a PAN homolog has been
verified in the closely related Rhesus Rhadinovirus (RRV), even
though the overlapping K7 open reading frame does not appear to
be conserved (K. Tycowski, S. Borah, M. Shu and J.A. Steitz,
manuscript in preparation) [65,66]. Additional studies are
required to explore the possibility that PAN RNA-like RNAs also
exist in more distantly-related viruses such as EBV and MHV-68.
Interestingly, the sequence of PAN-like RNAs may not be
conserved, whereas their abundance, nuclear localization and
the presence of a poly(A) tail may be critical for function.
Furthermore, there is no reason to expect that the role of PAN
RNA be fulfilled by a single RNA transcript. Perhaps in other
viruses, PAN RNA is functionally replaced by two or three
different polyadenylated, nuclear RNAs, which together sequester
PABPC1. Immunoprecipitation of PABPC1 from the nuclei of
other herpesviruses during the lytic phase and sequencing the
RNAs that co-precipitate might identify such PAN-like RNAs.
Interestingly, the best-characterized viral noncoding RNAs, the
VA RNAs of adenovirus, which facilitate viral translation by
suppressing protein kinase R and competitively inhibiting miRNA
export and processing [67,68], are not found outside of
adenoviruses. Perhaps their biological functions are fulfilled by
alternative mechanisms in other viruses.
Figure 8. Knockdown of PAN RNA reduces production of encapsulated viral DNA without affecting levels of intracellular viral DNA.
A. Knockdown of PAN RNA lowers viral yield in cell culture supernatant. BCBL1 TReX-RTA cells were electroporated with the indicated modified
oligonucleotides, allowed to recover overnight, and then induced with doxycycline. 8 days later, encapsulated viral DNA was harvested from the
supernatant and quantified by qPCR, normalizing to control plasmid exogenously added at onset of purification. Values are the average of 4
independent experiments. Standard error of the mean is shown. Note that electroporation of all oligonucleotides decreased virus production to some
degree, most probably because of cell death experienced upon electroporation of nucleic acids followed by lytic induction. B. Knockdown of PAN
RNA does not decrease intracellular viral DNA. BCBL1 TReX-RTA cells were treated as above and intracellular DNA was collected 3 days post-induction
and quantified by qPCR, normalizing to the amount of host DNA, as measured by GAPDH DNA signal. Values are the average of 3 independent
experiments. Standard error of the mean is shown.
doi:10.1371/journal.ppat.1002300.g008
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in the nucleus
By what molecular mechanism might PAN RNA enhance the
expression of late viral genes, and could this role be related to its
ability to bind re-localized PABPC1 in the nucleus of KSHV-
infected cells? It is first critical to understand why PABPC1 re-
localization might be harmful to the cell’s normal functioning.
PABPC1 is proposed to have three major functions: 1) to
synergistically enhance mRNA translation by interaction with
eIF4G, 2) to regulate mRNA fate by inhibiting deadenylation of the
poly(A)tailorpromotinginteractionwithdeadenylatingfactors,and
3) to facilitate nuclear export of mRNA [14]. It seems likely that loss
ofPABPC1fromthecytoplasmwouldbedetrimentaltoanyorallof
these functions in uninfected cells. In the context of viral infection,
re-localization of PABPC1 appears to be important for the shutoff
effect since siRNA-mediated knockdown of PABPC1 diminishesthe
ability of SOX to target GFP mRNA for degradation, and since
point mutations in SOX that ablate its effect on PABPC1 re-
localization also abolish its downregulation of host mRNAs [19].
Importantly, aspects of host shutoff have been recapitulated by
transient transfection of a nuclear targeted PABPC1 protein [24].
These results argue that it is not merely the absence of PABPC1
from the cytoplasm that is detrimental for host mRNA stability, but
that its presence in the nucleus is pivotal.
How might nuclear re-localized PABPC1 contribute to host
mRNA degradation? Under normal conditions, PABPN1 is
required for the synthesis of and co-transciptionally binds to the
newly-extended poly(A) tails of mRNAs. It has been suggested
that PABPN1 is further required for proper export of mRNA via
its interaction with nuclear export factors [63]. PABPC1, which
shuttles in and out of the nucleus, is also thought to aid in
mRNA export by interacting with polyadenylated mRNA at an
early stage in maturation [69,70,71,72,73]. The dramatic influx
of PABPC1 into the nucleus during KSHV lytic infection might
therefore perturb the process of mRNA nuclear export. Given
the extreme abundance of PABPC1 and its higher affinity for
poly(A) tails, nuclear PABPC1 (Kd ,7 nM) could displace
PABPN1 (Kd ,555 nM) from polyadenylated mRNAs and
interfere with PABPN1’s role in export [50,74]. As mRNAs that
are not properly processed and exported from the nucleus
become hyperadenylated and degraded [19,75,76,77], the re-
localization of PABPC1 to the nucleus could be the initiating
step in their degradation during shutoff (Fig. 9A and B). Similar
ideas are discussed in two recent studies, by Glaunsinger and
colleagues, on the inhibition of nuclear PABPC1 on mRNA
export [24,37].
If a highly abundant, inert, polyadenylated RNA were
expressed in the nucleus, then the re-localized PABPC1 would
be stoichiometrically bound, or nearly so. Thus, PAN RNA could
serve as a ‘‘buffer’’ against changes in nuclear PABPC1
concentration (Fig. 9C). The fact that host-cell encoded abundant,
nuclear polyadenylated RNAs, such as MALAT1 and NEAT1
RNA, do not accumulate to exceptionally high levels in response
to PABPC1 re-localization (Fig. 3) suggests that there is something
unique about PAN RNA. It should be noted that PABPN1
knockdown also diminishes SOX-mediated mRNA degradation,
so it may be the balance of the two proteins on the poly(A) tail that
is critical [19]. A comparison of intranuclear PABPC1 and
PABPN1 immunofluorescence signals relative to PAN RNA in situ
hybridization signal should be performed.
A challenge for the model (Fig. 9) is explaining how PAN RNA
specifically protects viral mRNAs. Should not host mRNAs be
equally protected from the negative effects of PABPC1 re-
localization by the abundant expression of PAN RNA? Some
possible explanations derive from fundamental differences be-
tween viral and host mRNAs in the nucleus. First, the viral Orf57
protein selectively binds intronless viral mRNAs, mediating their
export by anchoring the human transcription and export complex
(hTREX) [52]. Since most KSHV genes lack introns, Orf57 is not
only important, but in fact essential for virus replication [53].
Second, transcription rates of viral mRNAs appear to greatly
outpace those of host mRNAs during the lytic phase [23]. Thus,
viral mRNAs may be preferentially exported and translated during
the late lytic phase simply because they outcompete their host
counterparts. PAN RNA would therefore function in concert with
several other proteins (PABPN1 and PABPC1, SOX and Orf57) to
create an environment that favors the export and expression of
viral but not host mRNAs (Fig. 9C).
Supporting Information
Figure S1 Induction of PAN RNA in BCBL1 TReX-RTA cells
and purification of the PAN RNP from cell lysate. A. Northern
blot of total RNA harvested from BCBL1 TReX-RTA cells
treated with doxycycline for the indicated number of hours. B.
Northern blot of fractions collected during purification of the PAN
RNP by anion exchange and affinity chromatography steps from
lysate prepared at 24 hours post-induction.
(EPS)
Figure S2 Proteins identified by mass spectrometry, including
PABPC1 (top band), hnRNPC1 and hnRNPC2 (middle and
bottom bands), as co-purifying with PAN RNA. A. List of proteins
identified and the number of unique peptides identified for each
protein in each band. B. Silver-stained gel showing better
resolution of the top band, containing PABPC1, from a closely
migrating non-specific band, and a zoomed-in image of the silver-
stained gel in Fig. 1B showing the hnRNPC1 and C2 bands. C.
Links to complete mass spectrometry data for all three protein
bands.
(EPS)
Figure S3 Confocal images of PABPC1 (red) and rRNA (green)
in latent or lytic BCBL1 TReX-vector and TReX-RTA RTA
cells, respectively. Both cell lines were treated with 1 mg/mL
doxycycline for 24 hours before fixation and staining with anti-
PABPC1 and Y10B anti-rRNA antibodies. Red and green
channels merge into yellow in the cytoplasm of latently infected
cells, showing that both PABPC1 and rRNA are predominantly
cytoplasmic during latency. However, while PABPC1 (red) re-
localizes into the nucleus during lytic phase, rRNA (green) remains
cytoplasmic.
(EPS)
Figure S4 Manual scoring of images taken with a laser scanning
confocal microscope indicates that PAN RNA expression and
Figure 9. Model for PAN RNA sequestering nuclear re-localized PABPC1. A. mRNA transcription, export and translation during latent
infection. Host mRNAs (blue) are exported and bound by initiation factors and PABPC1. B. Viral infection in the absence of PAN RNA. SOX action
mediates host shutoff and PABPC1 nuclear re-localization. Host and viral mRNAs are bound by PABPC1, leading to inefficient processing and/or
export and resulting degradation. C. Viral infection in the presence of PAN RNA. As in B, PABPC1 is re-localized but bound by PAN RNA. Viral, but not
host, mRNAs are bound by Orf57, which mediates their efficient export into the cytoplasm.
doi:10.1371/journal.ppat.1002300.g009
Late Viral Protein Expression Depends on KSHV PAN RNA
PLoS Pathogens | www.plospathogens.org 16 October 2011 | Volume 7 | Issue 10 | e1002300PABPC1 re-localization are highly correlated. Left panels show
wide field images of PABPC1 (top, red) and PAN RNA (bottom,
green). Right panels show these same images, except that saturated
pixels are identified in white and background pixels are in gray.
Saturated and background signals aided scoring since cytoplasmic
PABPC1 stained very intensely compared to re-localized PABPC1
and since the anti-PAN RNA oligonucleotide probes described in
Materials and Methods sometimes gave significant background.
Images of representative regions in the lower 4 panels are
indicated by white boxes in the upper 4 panels. A total of 450 cells
were scored independently by two individuals. The percent of cells
with re-localized PABPC1 that also expressed PAN RNA was
scored as 73% by person 1 (larger sample size), and 90% by person
2 (smaller sample size), for an average score was 76%.
(TIF)
Figure S5 Replacing the poly(A) signal of PAN RNA with a U7
snRNP-dependent 39-end formation signal (PAN RNA D-poly(A)
tail) [6] reduces the effect of SOX co-transfection on PAN
accumulation in 293T cells, as viewed by confocal microscopy.
Note that some cells in which PABPC1 appears nuclear show
slightly enhanced signal even for PAN RNA lacking a poly(A) tail,
as indicated with white arrows, consistent with the northern blot
results (see Fig. 2A).
(TIF)
Figure S6 qRT-PCR analysis of GAPDH mRNA in total RNA
extracted from BCBL1 TReX-RTA cells that were electroporated
with the indicated modified oligonucleotides and induced with
doxycycline for the indicated times.
(EPS)
Figure S7 Immunoblots probed with anti-RTA, anti-vIL-6 and
anti-K8.1 antibodies, from 9 independent knockdown experi-
ments. Blots were developed either with a G:BOX (Syngene)
(panels A, B, C and E) or by x-ray film (panels D, F, G, H and I).
For the former, densitometry analysis was performed with
GeneTools software (Syngene), ensuring use of non-saturated
signal. Furthermore, linearity of signal was confirmed by titration
of lysate. For data collected with x-ray film, a titration of exposure
time was performed for each blot to avoid analysis of x-ray film
that had been overexposed. X-ray films were then scanned and
densitometry was performed using Image J software (NIH).
Average RTA, vIL-6 and K8.1 signal from cells treated with
mock, anti-GFP, anti-K7 and anti-PAN RNA oligonucleotides are
provided in Figure 6B.
(EPS)
Figure S8 Manual scoring of RTA and K8.1 expression in
BCBL1 TReX-RTA cells electroporated with no oligonucleotide
(mock), anti-GFP, anti-K7 or anti-PAN oligonucleotides. A.
Representative images from those used to score RTA and K8.1
expression in latently infected (top) and lytically infected (bottom)
cells. First, DAPI was used to identify healthy cells correctly
positioned on the z-axis (panels marked DAPI). Then, RTA-myc
expression was scored by overlaying the Alexa Fluor 594 signal
(panels marked DAPI+RTA). Finally, K8.1 expression was scored
by overlaying the Alexa Fluor 488 signal (panels marked
DAPI+RTA+K8.1). B. Quantification of 4 independent experi-
ments (except for the anti-K7 oligonucleotide transfection, where
n=3). 10 randomly chosen fields, each containing about 60–70
cells, were scored per treatment for each experiment. Standard
error of the mean is shown, and Student’s t-test values are as
follows: anti-GFP versus anti-K7=0.987, anti-GFP versus anti-
PAN=0.023, anti-K7 versus anti-PAN=0.045. For one of these 4
experiments, a second person independently scored K8.1 and
RTA expression, confirming a significant decline in K8.1
expression comparing anti-K7 and anti-PAN treated cells
(Student’s t-test=0.009). The difference between K8.1 expression
in anti-GFP versus anti-PAN treated cells was less significant, as
individually scored by this person (Student’s t-test=0.105).
(EPS)
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